The internationally recognized genomics, cancer, stem cell, bioengineering, information technology, engineering, language, pharmaceutical and dental research underway at the University of Maryland produces a robust pipeline of more than 250 new advances each year.

Our discovery portfolio contains an exciting mix of vaccines, drug targets, robotics, therapeutics, devices, software tools and cutting-edge techniques in virtually every discipline. All promise to make a quantifiable impact on society.

UM Ventures' Technology Transfer offices license innovations developed by faculty, students and staff to industry partners from early stage start-ups to industry giants. Our services include evaluating, patenting, and licensing intellectual property.

Search our portfolio available for licensing, learn about exciting UM startups looking for investment. Contact us for more information or to get started.